Chemical modification of the prototype CB1R ago-PAM, GAT211, yielded new CB1R allosteric modulators (-)-(,)- and (+)-(,)-, which showed significant bias for CB1R signaling pathways, as supported by docking studies. Compound efficiently lowered elevated intraocular pressure when it is due to an increase in endocannabinoid tone. This article may open new avenues to meet the therapeutic needs presented by glaucoma.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1021/acs.jmedchem.1c00843 | DOI Listing |
Publication Analysis
Top Keywords
"chemical magic"
4
magic" opened
4
opened prospects
4
prospects glaucoma?
4
glaucoma? chemical
4
chemical modification
4
modification prototype
4
prototype cb1r
4
cb1r ago-pam
4
ago-pam gat211
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!